Finance

Lists
Why is IKT down 3,55%?
Dive Deeper
IKT:NASDAQ
Inhibikase Therapeutics Inc
1,90 $
-3,55%
(-0,070) 1D
12 հոկ, 10:30:38 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IKT...
Open
1,95 $
High
1,95 $
Low
1,86 $
Mkt. cap
265,12 մլն
Avg. vol.
525,93 հզր
Volume
84,67 հզր
52-wk high
2,61 $
52-wk low
1,33 $
EPS
-0,44 $
Beta
0,89
Shares outstanding
139,54 մլն
No. of employees
35
Open
1,95 $
High
1,95 $
Low
1,86 $
Mkt. cap
265,12 մլն
Avg. vol.
525,93 հզր
Volume
84,67 հզր
52-wk high
2,61 $
52-wk low
1,33 $
EPS
-0,44 $
Beta
0,89
Shares outstanding
139,54 մլն
No. of employees
35
News stories
From web sources and news partners
About Inhibikase Therapeutics Inc
CEO-
Employees35
Founded2008
HeadquartersՈւիլմինգտոն, Դելավեր, Միացյալ Նահանգներ
Sector-
Websiteinhibikase.com
Analyst ratings
Based on 5 analysts giving stock ratings to IKT in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for IKT in the last 3 months.
Highest
Current 1,90 $
8,00 $ (+321,05%)
Average
6,40 $ (+236,84%)
Lowest
5,00 $ (+163,16%)
Analyst
Recommendation
Action
Price target
Projected
Date
Gaurav Maini
LifeSci Capital
Buy
Maintained
5,00 $
+163,2%
09/15/2026
Jason McCarthy
Maxim Group
Buy
Maintained
8,00 $
+321,1%
08/13/2026
Mazahir Alimohamed
Oppenheimer
Buy
Maintained
5,00 $
+163,2%
08/12/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
8,00 $
+321,1%
07/31/2026
Jason Zemansky
Bank of America Securities
Buy
Maintained
6,00 $
+215,8%
07/27/2026
Olivia Brayer
Cantor Fitzgerald
Buy
Maintained
4,00 $
+110,5%
05/18/2026
Aydin Huseynov
Ladenburg Thalmann & Co.
Buy
Initiated
4,00 $
+110,5%
03/04/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
7,65 մլն
-23,43 մլն
-
-
Cost of revenue
7,65 մլն
-23,43 մլն
-
-
Research and development expenses
-
22,39 մլն
10,84 մլն
13,39 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,61 մլն
6,77 մլն
7,38 մլն
7,66 մլն
Operating expense
5,61 մլն
29,17 մլն
18,22 մլն
21,05 մլն
Total operating expenses
13,26 մլն
5,73 մլն
18,22 մլն
21,05 մլն
Operating income
-13,26 մլն
-5,73 մլն
-18,22 մլն
-21,05 մլն
Other non operating income
-
-
1,46 մլն
1,46 մլն
EBT including unusual items
-11,93 մլն
-12,73 մլն
-16,38 մլն
-19,59 մլն
EBT excluding unusual items
-12,42 մլն
-4,69 մլն
-16,75 մլն
-19,59 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-11,93 մլն
-12,73 մլն
-16,38 մլն
-19,59 մլն
Net profit margin
-
-
-
-
Earnings per share
-
-
-0,10
-0,11
Interest and investment income
838,09 հզր
1,04 մլն
-
-
Interest expense
-
-
-
-
Net interest expenses
838,09 հզր
1,04 մլն
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-13,24 մլն
-5,73 մլն
-18,20 մլն
-21,04 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps